Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma.

[1]  A. Abioye,et al.  Pancreatic carcinoma. , 2020, Journal of the National Medical Association.

[2]  K. Ichimura,et al.  Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts. , 1999, Journal of neuropathology and experimental neurology.

[3]  D. Sanoudou,et al.  Acquired rearrangement of an amplified epidermal growth factor receptor (EGFR) gene in a human glioblastoma xenograft. , 1999, Journal of neuropathology and experimental neurology.

[4]  M. Bleavins,et al.  Genetic analysis of multiple loci in microsamples of fixed paraffin-embedded tissue. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  R. Hruban,et al.  Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. , 1998, Cancer research.

[6]  A. Andrén-sandberg,et al.  Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations , 1998, Genes, chromosomes & cancer.

[7]  S. Rodin,et al.  Strand asymmetry of CpG transitions as indicator of G1 phase-dependent origin of multiple tumorigenic p53 mutations in stem cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. O’Connell,et al.  Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. , 1998, Journal of the National Cancer Institute.

[9]  T. Mattfeldt,et al.  Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K‐ras mutations , 1998, The British journal of surgery.

[10]  R H Hruban,et al.  Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. , 1998, The American journal of surgical pathology.

[11]  J. Rüschoff,et al.  Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. , 1997, Cancer research.

[12]  C. Moskaluk,et al.  Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. , 1997, Cancer research.

[13]  J S Lee,et al.  Clonal genetic alterations in the lungs of current and former smokers. , 1997, Journal of the National Cancer Institute.

[14]  C. Moskaluk,et al.  p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. , 1997, Cancer research.

[15]  A. Gazdar,et al.  K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers , 1997, International journal of pancreatology : official journal of the International Association of Pancreatology.

[16]  J. Rüschoff,et al.  Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. , 1997, The American journal of pathology.

[17]  S. Goodman,et al.  Tumor-suppressive pathways in pancreatic carcinoma. , 1997, Cancer research.

[18]  G. Capellá,et al.  Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice. , 1996, Cancer research.

[19]  Carissa A. Sanchez,et al.  Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. , 1996, Oncogene.

[20]  H. Friess,et al.  A pancreatic cancer-specific expression profile. , 1996, Oncogene.

[21]  D. Hopwood.  Histological Typing of Tumours of the Exocrine Pancreas , 1996 .

[22]  P. Lichter,et al.  Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. , 1996, Cancer research.

[23]  T. Goodrow,et al.  Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. , 1996, Cancer research.

[24]  D. L. Sobin,et al.  Histological Typing of Tumours of the Exocrine Pancreas , 1996, World Health Organization International Histological Classification of Tumours.

[25]  C. Moskaluk,et al.  Homozygous deletion map at 18q21.1 in pancreatic cancer. , 1996, Cancer research.

[26]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[27]  A. Andrén-sandberg,et al.  Massive cytogenetic heterogeneity in a pancreatic carcinoma: Fifty‐four karyotypically unrelated clones , 1995, Genes, chromosomes & cancer.

[28]  P. Goodfellow,et al.  Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas , 1995, Genes, chromosomes & cancer.

[29]  R. Hruban,et al.  Allelotype of pancreatic adenocarcinoma using xenograft enrichment. , 1995, Cancer research.

[30]  Kathleen R. Cho,et al.  Frequency of homozygous deletion at p16/CDKN2 in primary human tumours , 1995, Nature Genetics.

[31]  M. Barrett,et al.  Genotypic analysis of multiple loci in somatic cells by whole genome amplification. , 1995, Nucleic acids research.

[32]  S. Stryker,et al.  Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. , 1994, The American journal of pathology.

[33]  F. Real,et al.  Comparative analysis of mutations in the p53 and K‐ras genes in pancreatic cancer , 1994, International journal of cancer.

[34]  R. Hruban,et al.  Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. , 1994, Cancer research.

[35]  R. Hruban,et al.  p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. , 1994, Cancer research.

[36]  S. Goodman,et al.  Overexpression of p53 protein in adenocarcinoma of the pancreas. , 1994, American journal of clinical pathology.

[37]  N. Pellegata,et al.  K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. , 1994, Cancer research.

[38]  Longnecker Ds.  THE QUEST FOR PRENEOPLASTIC LESIONS IN THE PANCREAS , 1994 .

[39]  A. Klein-Szanto,et al.  Immunohistochemical analysis of p53 expression in human pancreatic carcinomas. , 1994, Archives of pathology & laboratory medicine.

[40]  B. Vogelstein,et al.  An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms , 1994, The Journal of pathology.

[41]  J K McLaughlin,et al.  Pancreatitis and the risk of pancreatic cancer. , 1993, The New England journal of medicine.

[42]  A. Yanagisawa,et al.  Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. , 1993, Cancer research.

[43]  I. Baas,et al.  Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. , 1993, The American journal of pathology.

[44]  R. Hubert,et al.  Whole genome amplification from a single cell: implications for genetic analysis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[45]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[46]  P. Isaacson,et al.  Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.

[47]  Krisztina Boda,et al.  Complex evaluation of secretin-pancreozymin test data by multivariate statistical pattern recognition methods , 1986, International journal of pancreatology : official journal of the International Association of Pancreatology.

[48]  Nitin R. Patel,et al.  A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables , 1983 .

[49]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[50]  J. Bocsi,et al.  Establishment and long-term xenografting of human pancreatic carcinomas in immunosuppressed mice: changes and stability in morphology, DNA ploidy and proliferation activity , 1999, Journal of Cancer Research and Clinical Oncology.

[51]  A. Zalatnai.  Epidermal growth factor receptor, somatostatin and bcl-2 in human pancreatic tumor xenografts. An immunohistochemical study. , 1999, Pathology oncology research : POR.

[52]  A. Hartmann,et al.  Multiple mutation analyses in single tumor cells with improved whole genome amplification. , 1999, The American journal of pathology.

[53]  N. Maitland,et al.  Precise microdissection of human prostate cancers reveals genotypic heterogeneity. , 1998, Cancer research.

[54]  W. Schmiegel,et al.  Overexpression of p53 protein during pancreatitis. , 1997, British Journal of Cancer.

[55]  P. Wingo,et al.  Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.

[56]  Y. Shiratori,et al.  Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. , 1996, Gastroenterology.

[57]  D. Longnecker.  The quest for preneoplastic lesions in the pancreas. , 1994, Archives of pathology & laboratory medicine.

[58]  N. Lemoine,et al.  Ki-ras oncogene activation in preinvasive pancreatic cancer. , 1992, Gastroenterology.